Latest Listings And Ipos News

Macquarie Technology Group has landed a significant A$200 million hybrid capital injection from the Australian Government-backed National Reconstruction Fund Corporation, aimed at boosting sovereign digital infrastructure and cybersecurity services.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

ADX Energy has secured a crucial extension on its loan note repayments, unlocking financial flexibility to advance multiple drilling and development projects across Austria and Italy.

NH3 Clean Energy has received multiple engineering proposals for the Front End Engineering and Design (FEED) of its WAH2 clean ammonia project and commenced a detailed flora survey, marking significant progress toward its Final Investment Decision by year-end.

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

DPM Metals has lodged a detailed technical report updating the Mineral Resource and Reserve estimates for its Chelopech mine in Bulgaria, underpinning its strategic growth plans.

Sports Entertainment Group Limited has announced a significant on-market share buy-back program, aiming to repurchase up to 10% of its shares over the next year starting March 2026. The move reflects the board's confidence in the company's underlying value amid current market pricing.

FleetPartners Group Limited has announced a $20 million on-market share buy-back, reinforcing its strong balance sheet and commitment to shareholder returns alongside its existing dividend policy.

Queste Communications Ltd reported a positive net cash flow from operating activities for February 2026, supported by a robust cash balance and stable financing arrangements. The company’s consolidated position, including its majority stake in Orion Equities, underscores its solid liquidity outlook.

Novo Resources Corp. has issued a prospectus offering free New Options to recent placement participants and joint lead managers, aiming to support its exploration projects in Western Australia and Victoria. The options, exercisable at A$0.15 and expiring in three years, could raise significant capital upon exercise, subject to shareholder approval.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.